Bidirectional disruption of <i>GNAS</i> transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B

Y Yorihiro Iwasaki (Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School) M Monica Reyes (Endocrine Unit, Massachusetts General Hospital and Harvard Medical School) A Anna Ryabets-Lienhard (Center for Endocrinology, Diabetes, and Metabolism, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine) B Barbara Gales (Department of Pediatrics, Division of Pediatric Nephrology, University of California, Los Angeles, Geffen School of Medicine) A Agnès Linglart (Université Paris-Saclay, INSERM, Physiologie et Physiopathologie Endocriniennes) D Danny E. Miller I Isidro B. Salusky (Department of Pediatrics, Division of Pediatric Nephrology, University of California, Los Angeles, Geffen School of Medicine) M Murat Bastepe (Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School) H Harald Jüppner

Abstract

Pseudohypoparathyroidism type 1B (PHP1B) is a multihormone resistance disorder caused by aberrant GNAS methylation. Characteristic epigenetic changes at GNAS differentially methylated regions (DMRs), i.e., NESP, AS1, AS2, XL, and A/B, are associated with specific structural defects in different autosomal dominant PHP1B (AD-PHP1B) subtypes. However, mechanisms underlying abnormal GNAS methylation remain incompletely defined, largely because viable PHP1B mouse models are lacking. Using lymphoblastoid cells and induced pluripotent stem cells, we show that various GNAS methylation patterns in PHP1B reflect differential disruption of sense and antisense GNAS transcripts. In cases with broad GNAS methylation changes, loss of the maternal, sense-transcribed exon H/AS region impairs methylation of the AS1 DMR, which results in biallelic expression of an antisense transcript, GNAS-AS1 , and NESP hypermethylation. In contrast, cases with normal AS1 methylation, including STX16 deletions, show monoallelic GNAS-AS1 expression and normal NESP methylation. The roles of these GNAS transcripts were confirmed by a retrotransposon in GNAS-AS1 intron 1, identified in an AD-PHP1B family. This insertion impaired exon H/AS transcription when located on the maternal allele, thus preventing the complete establishment of methylation at all maternal GNAS DMRs, leading to biallelic GNAS-AS1 transcription. However, maternal GNAS-AS1 transcription was profoundly attenuated, thus allowing only a small gain-of-methylation at NESP. Likewise, on the paternal allele, the retrotransposon attenuated GNAS-AS1 transcription, thus preventing complete NESP methylation. Our findings support a model of bidirectional transcription-mediated regulation of methylation at GNAS DMRs and will help to refine systematic approaches for establishing molecular defects underlying different PHP1B subtypes.

Article Details

Volume / Issue Vol. 122, Issue 16
Published April 22, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

Y

Yorihiro Iwasaki

Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School

M

Monica Reyes

Endocrine Unit, Massachusetts General Hospital and Harvard Medical School

A

Anna Ryabets-Lienhard

Center for Endocrinology, Diabetes, and Metabolism, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine

B

Barbara Gales

Department of Pediatrics, Division of Pediatric Nephrology, University of California, Los Angeles, Geffen School of Medicine

A

Agnès Linglart

Université Paris-Saclay, INSERM, Physiologie et Physiopathologie Endocriniennes

D

Danny E. Miller

I

Isidro B. Salusky

Department of Pediatrics, Division of Pediatric Nephrology, University of California, Los Angeles, Geffen School of Medicine

M

Murat Bastepe

Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School

H

Harald Jüppner